Hong Seng Technology

Hong Seng Consolidated Berhad is a Malaysian conglomerate that has established a significant presence in the healthcare and life sciences sectors through its subsidiary, HS Bio. The company specializes in molecular diagnostics, genomic sequencing, and clinical laboratory management, providing end-to-end services from testing to data analysis. It gained international attention during the COVID-19 pandemic for its large-scale screening operations and the development of the HealthSeng digital health platform. Through strategic partnerships with global leaders like Illumina, the company is advancing precision medicine and genomic research in Southeast Asia. Additionally, Hong Seng is involved in the distribution of medical supplies and the operation of integrated medical hubs. Its business model focuses on leveraging technology to improve healthcare accessibility and diagnostic accuracy.